|
ML335
- 英文名称：ML335
- 品牌：WYTSCI
- 产地：进口
- 型号：1MG
- 货号：WT-AY-B10961
- cas：825658-06-8
- 价格： ￥1/mg
- 发布日期： 2025-04-10
- 更新日期： 2025-05-23
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B10961 |
| 用途 | 科研检测 |
| 英文名称 | ML335 |
| 包装规格 | 1MG |
| CAS编号 | 825658-06-8 |
| 别名 | ML335 |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:98% by TLC;NMR (Conforms)
分子式:C15H14Cl2N2O3S
分子量:373.25
溶剂:DMSO (50 mg/ml) Ethanol (20 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):TREK-1,2 activator
Function / Pharmacology:Two-pore domain potassium (K2P) channels of the TREK subfamily regulate neuronal excitability, influence pain, temperature perception and responses to anaesthetics. ML335 is a novel, selective TREK-1,2 activator with EC50s of 14.3 and 5.2 ?M1. It represents an important new pharmacological tool for studying the physiology of TREK channels.
分子式:C15H14Cl2N2O3S
分子量:373.25
溶剂:DMSO (50 mg/ml) Ethanol (20 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):TREK-1,2 activator
Function / Pharmacology:Two-pore domain potassium (K2P) channels of the TREK subfamily regulate neuronal excitability, influence pain, temperature perception and responses to anaesthetics. ML335 is a novel, selective TREK-1,2 activator with EC50s of 14.3 and 5.2 ?M1. It represents an important new pharmacological tool for studying the physiology of TREK channels.
